 |
Download the the Pulse of CRF Summer 2010 Newsletter (301 KB, PDF) |
Message from the Faculty
Welcome to the Cardiovascular Research Foundation’s Summer Newsletter. The temperature has been rising and so has our anticipation for TCT 2010, which this year returns to Washington, DC, on September 21-25.
TCT 2010 will feature the most ambitious and comprehensive program CRF has ever put together. We have lined up a wide variety of late breaking clinical trials covering the entire range of cardiovascular topics. Landmark studies and clinical trials related to the next generation of interventional cardiology techniques and therapies will be presented in a series of Main Arena presentations and press conferences. These findings, along with hundreds of scientific abstract presentations, will have the potential to dramatically affect patient care. In addition, numerous scientific symposia will offer thorough reviews of all the different facets of interventional cardiology. Attendees will find an expanded emphasis on interactive case review sessions as well as more than 100 live cases performed by world leaders at 18 international sites and televised in high definition.
Attendees also will be treated to something new this year: TCT for the Practitioner—called ‘TCT in 3’ because it is concentrated into three days for the busy interventional cardiologist—will emphasize patient care topics and practice management skills. In addition, there will be summary sessions aimed at reviewing and synthesizing the emerging science and lessons from the meeting for use in everyday clinical practice.
Another key meeting for CRF, Transcatheter Valve Therapies (TVT) in Seattle, WA, in June, welcomed almost 500 attendees (a 45% increase over last year). Attendees participated in comprehensive discussions concerning the therapeutic options for treating valvular heart disease. The workshop provided a unique opportunity for hands-on learning in a cadaveric lab and updates on the development and clinical investigation of percutaneous heart valves, one of the most exciting new areas in interventional cardiology today.
As always, I wish to thank the CRF staff and faculty for their tireless efforts in making TVT so successful and getting ready for TCT. All of us are looking forward to a year’s worth of preparation paying off in an exciting learning experience for the thousands of TCT attendees as well as our own faculty—one that will ultimately result in improved care for our patients.
Sincerely,
Martin B. Leon, MD
Founder and Chairman Emeritus
Co-Director, Medical Research and Education Division
Cardiovascular Research Foundation
Gregg W. Stone, MD
Co-Director, Medical Research and Education Division
Cardiovascular Research Foundation
